Stockscreener 앱 받기
1.40
4.11%
-0.06
시간 외 거래:
1.40
전일 마감가:
$1.46
열려 있는:
$1.47
하루 거래량:
489.81K
Relative Volume:
0.40
시가총액:
$396.60M
수익:
-
순이익/손실:
$-125.04M
주가수익비율:
-1.7073
EPS:
-0.82
순현금흐름:
$-122.99M
1주 성능:
+0.72%
1개월 성능:
-4.11%
6개월 성능:
-11.95%
1년 성능:
-43.78%
1일 변동 폭
$1.38
$1.47
1주일 범위
$1.355
$1.54
52주 변동 폭
$1.01
$3.305
Erasca Inc Stock (ERAS) Company Profile
명칭
Erasca Inc
전화
(858) 465-6511
주소
10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO
ERAS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
1.40 | 405.10M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-26 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | Jefferies | Buy |
| 2024-03-11 | 개시 | CapitalOne | Overweight |
| 2024-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-10-11 | 개시 | H.C. Wainwright | Buy |
| 2023-03-30 | 개시 | Mizuho | Buy |
| 2023-02-24 | 개시 | Goldman | Buy |
| 2023-02-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Erasca Inc 주식(ERAS)의 최신 뉴스
Using data tools to time your Erasca Inc. exitSwing Trade Planning with Consistent Setup - Newser
How moving averages guide Erasca Inc. tradingGrowth Projection Summary for Long-Term Investors - Newser
What technical models suggest about Erasca Inc.’s comebackAI Intraday Market Movement Prediction Tool - Newser
Is it too late to sell Erasca Inc.Weekly Breakout Forecast with Entry Zones - Newser
Published on: 2025-08-09 05:39:08 - Newser
Multi factor analysis applied to Erasca Inc.Sector-Wise Stock Strength Trend Analysis - Newser
Erasca (ERAS) to Release Quarterly Earnings on Monday - Defense World
Technical analysis overview for Erasca Inc. stockDaily Entry Opportunity Forecasting Tool - Newser
Erasca Inc. stock momentum explainedEarly Entry Planner for Swing Candidates - Newser
When is the best time to exit Erasca Inc.Free Real Market Momentum Signal Generator - Newser
Brokerages Set Erasca, Inc. (NASDAQ:ERAS) PT at $4.57 - Defense World
How to build a dashboard for Erasca Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser
Can Erasca Inc. Rally Enough to Break EvenWeekly Chart Analysis With Entry Advice Provided - metal.it
Heatmap Data Shows High Activity in Erasca Inc. SectorLow Risk Swing Trade Opportunities Identified - metal.it
Erasca discloses new GTPase KRAS mutant inhibitors - BioWorld MedTech
Fibonacci Levels Suggest Recovery for Erasca Inc.Consistent Gain Investment Strategies Emerge - beatles.ru
Why is Erasca Inc. stock attracting strong analyst attentionFree Predictions - Jammu Links News
What analysts say about Erasca Inc. stockFastest-growing stock picks - Jammu Links News
Erasca Receives FDA Clearance for First-in-Class Pan-KRAS Inhibitor, ERAS-4001, for Solid Tumors - MSN
Is it the right time to buy Erasca Inc. stockTap into rapid wealth building techniques - Jammu Links News
Is Erasca Inc. stock overvalued or undervaluedCapitalize on proven investment strategies - Jammu Links News
What catalysts could drive Erasca Inc. stock higher in 2025Massive portfolio appreciation - Jammu Links News
Published on: 2025-08-04 01:33:01 - Jammu Links News
When is Erasca Inc. stock expected to show significant growthGet professional guidance for market timing - Jammu Links News
How does Erasca Inc. compare to its industry peersDiscover market opportunities with expert help - Jammu Links News
What makes Erasca Inc. stock price move sharplyAchieve rapid portfolio growth with expert guidance - Jammu Links News
What is Erasca Inc. company’s growth strategyFree Daily Trading Room Entry - Jammu Links News
Is Erasca Inc. a growth stock or a value stockMaximize gains with data-driven stock picks - Jammu Links News
Predicting Erasca Inc. trend using moving averagesFree Daily Profit Focused Stock Screener - Newser
What institutional investors are buying Erasca Inc. stockGrow your portfolio with growth-oriented stocks - Jammu Links News
How does Erasca Inc. generate profit in a changing economyUnlock powerful stock screening tools - Jammu Links News
Trend Reversal Possible in Erasca Inc. Charts IndicateWeekly Stock Watch With Growth Focus Expanded - beatles.ru
What are analysts’ price targets for Erasca Inc. in the next 12 monthsInvest smarter with data-backed insights - Jammu Links News
How to track smart money flows in Erasca Inc.Weekly Hot Stocks Based on Volume Flow - Newser
What are Erasca Inc. company’s key revenue driversPost Market Target Finder For Every Investor - Jammu Links News
How many analysts rate Erasca Inc. as a “Buy”Financial News Planner For Beginners - Jammu Links News
Erasca Inc (ERAS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):